Identification and fine mapping of structural variation Segment to Dominate APAC Long Read Sequencing Market during 2021–2028
According to The Insight Partners market research study on “APAC Long Read Sequencing Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Technology, Product, Application, Workflow and End User” is expected to reach US$ 1,095.21 million by 2028 from US$ 250.33 million in 2021. The market is estimated to grow at a CAGR of 23.5% from 2021 to 2028. The report provides trends prevailing in the APAC long read sequencing market along with the drivers and restraints pertaining to the market growth. Growth in funding for genomics is the major factor driving the growth of the APAC long read sequencing market. However, issues associated with the absence of skilled professionals hinder the growth of APAC long read sequencing market.
The APAC long read sequencing market is segmented based on technology, product, application, workflow and end user, and country. Based on technology, the long read sequencing market is sub-segmented into single-molecule real-time sequencing (SMRT), nanopore sequencing, and loop genomics long-read sequencing. The single-molecule real-time sequencing (SMRT) segment dominated the market in 2020 and loop genomics long-read sequencing segment is expected to be the fastest growing during the forecast period. Based on product, the long read sequencing market is categorized into instruments, consumables, and services. The consumables segment dominated the market in 2020 and services segment is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into identification and fine mapping of structural variation, tandem repeat sequencing, pseudogene discrimination, resolving allele phasing, reproductive genomics, cancer, viral and microbial sequencing. The identification and fine mapping of structural variation segment dominated the market in 2020 and cancer segment is expected to be the fastest growing during the forecast period. Based on workflow, the market is segmented pre-sequencing, sequencing, and data analysis. The sequencing segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on end user, the long read sequencing market is sub-segmented into academic research institutes, hospitals and clinics, and pharma and biotechnology companies. The academic research institutes, hospitals and clinics segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on country, the market is segmented into Japan, China, India, South Korea, and Australia.
In January 2020, after a series of pneumonia cases in Wuhan, the Chinese health authorities, the capital city of Hubei province (China), announced that a novel coronavirus, officially known as severe acute respiratory syndrome coronavirus (SARS-CoV)-2, was responsible for these cases. In mid-January 2020, researchers in China and Australia published the whole genome sequence of SARS-CoV-2. The genomics helped understand SARS-CoV-2, which enabled governments and researchers to track the emergence of Covid-19 outbreaks in their country. The World Health Organization demands an increase in genomic sequencing of the coronavirus after the detection of the new virus strain. For instance, in India, the health ministry has installed the Indian SARS-CoV-2 Genomics Consortium (INSACOG) for laboratory and epidemiological surveillance and develops the virus's whole-genome sequencing, helping in understanding the virus transmission and evolution. Market players realized the importance of genomics in the treatment of COVID 19, which is expected to raise demand for genomic during the forecast period. For instance, the Singapore-incorporated medtech company Cell ID Pte. Ltd. developed a palm-sized portable genetic test kit that uses an app on a laptop to detect, anywhere, anytime, if a person is affected COVID-19. Dubbed the Quiz PCR Biochip, the test uses biotechnology to perform two tests at a time outside of the laboratory. The rising research activities on the COVID-19 virus are paving the way for potential opportunities for start-ups and established businesses. For instance, Haystack Analytics, a start-up company in Mumbai, Maharashtra, is using genomics to study the transmission of the virus and help the government of India. Thus, the increasing demand for genomics is due to rising cases of COVID-19 is driving the growth of the market in the forecasted period.
Bionano Genomics; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Longas Technologies; Oxford Nanopore Technologies; Pacific Biosciences of California, Inc.; and PerkinElmer, Inc. among the leading companies in the APAC long read sequencing market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, The Oxford Nanopore Ultra-Long DNA Sequencing Kit, when used in conjunction with Circulomics Nanobind Kits, is designed to maximise the number of ultra-long reads and has allowed the continuous sequencing of single DNA fragments of up to 3+ Mb externally and 4+ Mb internally. Using this method, users can achieve more than 100 reads over 1 Mb per PromethION flow cell run.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com